Form 4: Astronics Corp Executive Vice President Michael Kuehn Reports Stock Transactions
SEC Form 4
Executive Vice President Michael Kuehn reports transactions involving Astronics Corp stock, including sales, acquisitions, and vesting of restricted stock units.
Summary
- Michael Kuehn, Executive Vice President of Astronics Corp, filed a Form 4 detailing changes in beneficial ownership.
- On February 29, 2024, Kuehn sold 2,209 shares of Astronics Corp stock at a price of $20.16 per share.
- On March 8, 2024, Kuehn acquired 7,838 shares through the vesting of restricted stock units.
- Also on March 8, 2024, Kuehn acquired 226 shares through the vesting of restricted stock units.
- Shares were withheld to satisfy tax obligations related to the vesting of restricted stock units on March 8, 2024.
- Kuehn also holds options to purchase shares of Astronics Corp stock at various exercise prices and expiration dates.
- The vesting of certain restricted stock units is contingent upon Astronics Corp's average annual adjusted EBITDA for specified periods.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transactions are routine and don't strongly indicate positive or negative sentiment. The sale of shares is balanced by the vesting of restricted stock units.
Positives
- The vesting of restricted stock units indicates that Astronics Corp is meeting some performance targets, as these units are often tied to company performance metrics like EBITDA.
- The executive's continued holding of a significant number of shares and options suggests confidence in the company's long-term prospects.
Negatives
- The sale of 2,209 shares by the executive could be interpreted negatively, although it may be for personal financial reasons and not necessarily indicative of a lack of confidence in the company.
Risks
- The vesting of restricted stock units is tied to Astronics Corp's average annual adjusted EBITDA, creating a risk that the units may not fully vest if the company underperforms.
- Fluctuations in the company's stock price could impact the value of the executive's holdings and potentially influence future trading decisions.
Future Outlook
The vesting of future restricted stock units is dependent on the company's average annual adjusted EBITDA performance over specified periods, indicating a performance-based incentive structure.
Industry Context
Executive stock transactions are common and closely watched indicators of management's sentiment and alignment with shareholder interests. These transactions can be compared to those of executives at competitor companies to gauge relative confidence in their respective firms.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders, a practice common across publicly traded companies.
- The vesting conditions tied to EBITDA performance are a standard method for incentivizing executives to achieve specific financial targets, similar to practices at companies like Boeing or Airbus in the aerospace industry.
- Comparing the option exercise prices and vesting schedules to those of executives at similar-sized aerospace and defense companies can provide insights into the competitiveness of Astronics Corp's compensation structure.
Stakeholder Impact
- Shareholders may view the executive's transactions as a reflection of their confidence in the company's performance.
- Employees may be motivated by the performance-based vesting of restricted stock units, as it aligns their interests with the company's financial success.
Key Dates
| Date | Description |
|---|---|
| 12/12/2018 | Date of grant for options with an exercise price of $35.61 and an expiration date of 12/12/2027. |
| 12/13/2019 | Date of grant for options with an exercise price of $31.57 and an expiration date of 12/13/2028. |
| 12/09/2020 | Date of grant for options with an exercise price of $30.04 and an expiration date of 12/09/2029. |
| 01/22/2022 | Date of grant for options with an exercise price of $14.45 and an expiration date of 01/22/2031. |
| 12/09/2022 | Date of grant for options with an exercise price of $11.13 and an expiration date of 12/09/2031. |
| 12/16/2023 | Date of grant for options with an exercise price of $9.74 and an expiration date of 12/16/2032. |
| 02/29/2024 | Date of transaction where 2,209 shares were sold at $20.16 per share. |
| 03/08/2024 | Date of transactions involving the vesting of restricted stock units. |
| 12/07/2024 | Date of grant for options with an exercise price of $15.15 and an expiration date of 12/07/2033. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.